Clinical Trials Browser

Phase 2 × Unresectable Sinonasal Tumors × Doxorubicin × Clear all

NCT02099188 2023-03-13

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

Phase 2 Unknown

Unresectable Sinonasal Tumors